Wisdomont Biotech Fund LLC
Oceaniq Capital · adviser of record: Oceaniq Capital, LLC · 2019 vintage
Wisdomont Biotech Fund LLC is a 2019 venture fund managed by Oceaniq Capital, with $960k raised (Form D, amount sold). It reported $340k in gross assets at year-end 2023, 0.35x its size, against a peak of $1mm in 2021.
- Latest value held
- $340k year-end 2023
- Peak
- $1mm year-end 2021
- Fund size
- $960k Form D, amount sold
- Held vs. size
- 0.35x peak 1.08x
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2023 | $340k | 0.35x | +0% |
| 2022 | $340k | 0.35x | -67% |
| 2021 | $1mm | 1.08x | +31% |
| 2020 | $787k | 0.82x | – |
Other funds from Oceaniq Capital
- Forest Mobility Fund LLC 2020
- Oceaniq Partners Fund II 2018
- Oceaniq Partners/Base Venture Series LLC 2017
- Oceaniq Partners/Paxata Series, LLC 2017
- Oceaniq Partners/Game Series, LLC 2017
- Oceaniq Partners/Autonomous Driving Series, LLC 2017
- Oceaniq Partners/Data Scientist Series, LLC 2017
- Oceaniq Partners Fund II/Gene Editing Class, LLC 2017
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-7380401778. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.